305 related articles for article (PubMed ID: 17586745)
1. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
André P; Balkau B; Vol S; Charles MA; Eschwège E;
Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
[TBL] [Abstract][Full Text] [Related]
3. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
André P; Balkau B; Born C; Charles MA; Eschwège E;
Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
[TBL] [Abstract][Full Text] [Related]
4. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.
Kang YH; Min HK; Son SM; Kim IJ; Kim YK
Diabetes Res Clin Pract; 2007 Aug; 77(2):306-13. PubMed ID: 17353063
[TBL] [Abstract][Full Text] [Related]
5. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
[TBL] [Abstract][Full Text] [Related]
6. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
7. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Vari IS; Balkau B; Kettaneh A; André P; Tichet J; Fumeron F; Caces E; Marre M; Grandchamp B; Ducimetière P;
Diabetes Care; 2007 Jul; 30(7):1795-801. PubMed ID: 17416791
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
[TBL] [Abstract][Full Text] [Related]
9. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
10. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
12. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
13. Association of gamma-glutamyltransferase with incidence of type 2 diabetes in Japan.
Fujita M; Ueno K; Hata A
Exp Biol Med (Maywood); 2010 Mar; 235(3):335-41. PubMed ID: 20404051
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors.
Levinger I; Goodman C; Peake J; Garnham A; Hare DL; Jerums G; Selig S
Diabet Med; 2009 Mar; 26(3):220-7. PubMed ID: 19317815
[TBL] [Abstract][Full Text] [Related]
15. Association between serum gamma-glutamyltransferase and acute ischemic nonembolic stroke in elderly subjects.
Korantzopoulos P; Tzimas P; Kalantzi K; Kostapanos M; Vemmos K; Goudevenos J; Elisaf M; Milionis H
Arch Med Res; 2009 Oct; 40(7):582-9. PubMed ID: 20082873
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
[TBL] [Abstract][Full Text] [Related]
17. Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population.
Lee MY; Koh SB; Koh JH; Nam SM; Shin JY; Shin YG; Kong ID; Ryu SY; Lee TY; Park JK; Chung CH
Diabet Med; 2008 Apr; 25(4):469-75. PubMed ID: 18346161
[TBL] [Abstract][Full Text] [Related]
18. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
Meisinger C; Löwel H; Heier M; Schneider A; Thorand B;
J Intern Med; 2005 Dec; 258(6):527-35. PubMed ID: 16313476
[TBL] [Abstract][Full Text] [Related]
19. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
Ferreira I; Boreham CA; Twisk JW; Gallagher AM; Young IS; Murray LJ; Stehouwer CD
J Hypertens; 2007 May; 25(5):1009-20. PubMed ID: 17414665
[TBL] [Abstract][Full Text] [Related]
20. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies.
Liu CF; Zhou WN; Fang NY
Int J Clin Pract; 2012 Jul; 66(7):692-8. PubMed ID: 22698421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
